Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of GBP 191.42 million. The enterprise value is 192.42 million.

Market Cap	191.42M
Enterprise Value	192.42M

Important Dates

The next estimated earnings date is Thursday, September 18, 2025.

Earnings Date	Sep 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	47.40M
Shares Outstanding	n/a
Shares Change (YoY)	+27.99%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-32.19
PB Ratio	-3.52
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.42
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.41

Financial Position

The company has a current ratio of 1.04

Current Ratio	1.04
Quick Ratio	0.98
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.50
Interest Coverage	-8.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-52.89%
Return on Invested Capital (ROIC)	-251.54%
Return on Capital Employed (ROCE)	-804.64%
Revenue Per Employee	-55,055
Profits Per Employee	-521,695
Employee Count	108
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Nanobiotix has paid 83,524 in taxes.

Income Tax	83,524
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.75% in the last 52 weeks. The beta is 1.32, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	-13.75%
50-Day Moving Average	3.77
200-Day Moving Average	3.62
Relative Strength Index (RSI)	68.89
Average Volume (20 Days)	5,853

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanobiotix had revenue of GBP -5.95 million and -56.34 million in losses. Loss per share was -1.19.

Revenue	-5.95M
Gross Profit	-5.95M
Operating Income	-56.45M
Pretax Income	-56.26M
Net Income	-56.34M
EBITDA	-55.96M
EBIT	-56.45M
Loss Per Share	-1.19

Full Income Statement

Balance Sheet

The company has 41.13 million in cash and 42.09 million in debt, giving a net cash position of -963,420.

Cash & Cash Equivalents	41.13M
Total Debt	42.09M
Net Cash	-963,420
Net Cash Per Share	n/a
Equity (Book Value)	-54.34M
Book Value Per Share	-1.15
Working Capital	2.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.17 million and capital expenditures -699,616, giving a free cash flow of -16.87 million.

Operating Cash Flow	-16.17M
Capital Expenditures	-699,616
Free Cash Flow	-16.87M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	949.35%
Pretax Margin	946.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.99%
Shareholder Yield	n/a
Earnings Yield	-29.43%
FCF Yield	-8.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -3.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.73
Piotroski F-Score	1